AR046971A1 - Aminobenzoimidazoles y benzoimidazoles como inhibidores de la replicacion del virus sincitial respiratorio - Google Patents
Aminobenzoimidazoles y benzoimidazoles como inhibidores de la replicacion del virus sincitial respiratorioInfo
- Publication number
- AR046971A1 AR046971A1 ARP040104806A ARP040104806A AR046971A1 AR 046971 A1 AR046971 A1 AR 046971A1 AR P040104806 A ARP040104806 A AR P040104806A AR P040104806 A ARP040104806 A AR P040104806A AR 046971 A1 AR046971 A1 AR 046971A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyloxy
- alkyl
- r4ar4b
- aminobenzoimidazoles
- benzoimidazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Aminobenzoimidazoles y benzoimidazoles que tiene actividad inhibidora de la replicacion del VSR y que tienen la formula (1) sus profármacos, N-oxidos, sales de adicion, aminas cuaternarias, complejos metálicos y formas estereoquímicamente isoméricas, en los que G es un enlace directo o alcandiilo C1-10 sustituido de manera opcional con uno o más hidroxi, alquiloxi C1-6, Ar1-alquiloxi C1-6, alquiltio C1-6, Ar1-alquiltio C1-6, HO(-CH2-CH2-O)n-, alquiloxi C1-6(-CH2-CH2-O)n- o Ar1- alquiloxi C1-6(-CH2-CH2-O)n-; R1 es Ar1 o un heterociclo monocíclico o bicíclico; Q es H, amino o mono- o di(alquil C1-4)amino; uno de R2a y R3a se selecciona de halo, alquilo C1-6 opcionalmente mono- o polisustituido, alquenilo C2-6 opcionalmente mono- o polisustituido, nitro, hidroxi, Ar2, N(R4aR4b), N(R4aR4b)sulfonilo; N(R4aR4b)carbonilo, alquiloxi C1-6, Ar2oxi, Ar2 alquiloxi C1-6, carboxilo, alquiloxicarbonilo C1-6 o -C(=Z)Ar2; y el otro de R2a y R3a es H; en el caso que R2a sea diferente de H entonces R2b es H, alquilo C1-6 o halogeno y R3b es H; en el caso que R3a sea diferente de H entonces R3b es H, alquilo C1-6 o halogeno y R2b es H. Composiciones que contienen estos compuestos como componente activo y procesos para preparar estos compuestos y composiciones.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03104797 | 2003-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR046971A1 true AR046971A1 (es) | 2006-01-04 |
Family
ID=34924148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040104806A AR046971A1 (es) | 2003-12-18 | 2004-12-20 | Aminobenzoimidazoles y benzoimidazoles como inhibidores de la replicacion del virus sincitial respiratorio |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8044073B2 (es) |
| EP (1) | EP1697343B1 (es) |
| JP (1) | JP4915734B2 (es) |
| CN (1) | CN1918146B (es) |
| AR (1) | AR046971A1 (es) |
| AT (1) | ATE435222T1 (es) |
| AU (1) | AU2004298457B2 (es) |
| BR (1) | BRPI0417811A (es) |
| CA (1) | CA2548657A1 (es) |
| DK (1) | DK1697343T3 (es) |
| ES (1) | ES2328700T3 (es) |
| MY (1) | MY141292A (es) |
| NZ (1) | NZ547796A (es) |
| PL (1) | PL1697343T3 (es) |
| PT (1) | PT1697343E (es) |
| RU (1) | RU2379302C2 (es) |
| TW (1) | TWI356055B (es) |
| WO (1) | WO2005058869A1 (es) |
| ZA (1) | ZA200605893B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR046959A1 (es) * | 2003-12-18 | 2006-01-04 | Tibotec Pharm Ltd | Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio |
| AU2006260969B2 (en) | 2005-06-20 | 2011-11-17 | Janssen Sciences Ireland Uc | 1- ( 2-amino-3- (substituted alkyl)-3H-benzimidazolylmethyl) -3-substituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus |
| BRPI0720564A2 (pt) | 2006-12-22 | 2011-08-16 | Avexa Ltd | pirimidinonas biciclìcas e seus usos |
| RU2014137448A (ru) | 2012-02-17 | 2016-04-10 | Эббви Инк. | Диаминопиримидины, пригодные в качестве ингибиторов респираторно-синцитиального вируса человека (rsv) |
| CN114716426A (zh) | 2013-08-21 | 2022-07-08 | 詹森生物制药有限公司 | 抗病毒化合物 |
| MA41614A (fr) | 2015-02-25 | 2018-01-02 | Alios Biopharma Inc | Composés antiviraux |
| TW201813963A (zh) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201815787A (zh) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201825465A (zh) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| AR111295A1 (es) | 2017-03-20 | 2019-06-26 | Forma Therapeutics Inc | Composiciones de pirrolopirrol como activadores de piruvato quinasa (pkr) |
| US10881666B2 (en) | 2017-09-29 | 2021-01-05 | Enanta Pharmaceuticals, Inc. | Combination pharmaceutical agents as RSV inhibitors |
| EP3594205A1 (en) | 2018-07-09 | 2020-01-15 | Abivax | Phenyl-n-aryl derivatives for treating a rna virus infection |
| EP3594206A1 (en) | 2018-07-09 | 2020-01-15 | Abivax | Phenyl-n-quinoline derivatives for treating a rna virus infection |
| WO2020061255A1 (en) | 2018-09-19 | 2020-03-26 | Forma Therapeutics, Inc. | Activating pyruvate kinase r |
| US20200129485A1 (en) | 2018-09-19 | 2020-04-30 | Forma Therapeutics, Inc. | Treating sickle cell disease with a pyruvate kinase r activating compound |
| RS67259B1 (sr) | 2019-09-19 | 2025-10-31 | Novo Nordisk Healthcare Ag | Kompozicije koje aktiviraju piruvat kinazu r (pkr) |
| US12128035B2 (en) | 2021-03-19 | 2024-10-29 | Novo Nordisk Health Care Ag | Activating pyruvate kinase R |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE31812B1 (en) * | 1967-02-03 | 1973-01-10 | Merck & Co Inc | Benzimidazole derivatives |
| US4179505A (en) * | 1977-03-30 | 1979-12-18 | Janssen Pharmaceutica N.V. | 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives |
| CA1140119A (en) | 1978-04-03 | 1983-01-25 | Joseph Torremans | N-heterocyclyl-4-piperidinamines |
| US4492708A (en) * | 1982-09-27 | 1985-01-08 | Eli Lilly And Company | Antiviral benzimidazoles |
| KR100190299B1 (ko) | 1990-07-19 | 1999-06-01 | 디르크 반테 | 신규한 옥사졸릴 유도체 |
| JPH09505029A (ja) * | 1993-07-19 | 1997-05-20 | 藤沢薬品工業株式会社 | ドパミン受容体作動薬、５−ＨＴ受容体拮抗薬あるいはα▲下１▼受容体拮抗薬として有用なベンズイミダゾール誘導体 |
| US5545653A (en) * | 1995-06-07 | 1996-08-13 | Eli Lilly And Company | Anti-viral compounds |
| CA2227688C (en) | 1998-01-16 | 2007-07-31 | James W. Critchfield | Methods and compositions for inhibition of viral replication |
| ES2215683T3 (es) * | 1999-06-28 | 2004-10-16 | Janssen Pharmaceutica N.V. | Inhibidores de la replicacion del virus sincitial respiratorio. |
| CZ20014574A3 (cs) * | 1999-06-28 | 2002-05-15 | Janssen Pharmaceutica N. V. | Inhibitory replikace respiračně syncyciálního viru |
| CZ20014573A3 (cs) * | 1999-06-28 | 2002-05-15 | Janssen Pharmaceutica N. V. | Inhibitory replikace respiračně syncyciálního viru |
| EP1383760A1 (en) | 2001-04-30 | 2004-01-28 | Fujisawa Pharmaceutical Co., Ltd. | Biarylcarboxamide compounds as apolipoprotein b inhibitors |
| US7030150B2 (en) * | 2001-05-11 | 2006-04-18 | Trimeris, Inc. | Benzimidazole compounds and antiviral uses thereof |
| FR2833948B1 (fr) | 2001-12-21 | 2004-02-06 | Sod Conseils Rech Applic | Nouveaux derives de benzimidazole et leur utilisation en tant que medicament |
-
2004
- 2004-12-20 WO PCT/EP2004/053613 patent/WO2005058869A1/en not_active Ceased
- 2004-12-20 AU AU2004298457A patent/AU2004298457B2/en not_active Ceased
- 2004-12-20 DK DK04804949T patent/DK1697343T3/da active
- 2004-12-20 AT AT04804949T patent/ATE435222T1/de active
- 2004-12-20 BR BRPI0417811-4A patent/BRPI0417811A/pt not_active IP Right Cessation
- 2004-12-20 JP JP2006544463A patent/JP4915734B2/ja not_active Expired - Fee Related
- 2004-12-20 PL PL04804949T patent/PL1697343T3/pl unknown
- 2004-12-20 ES ES04804949T patent/ES2328700T3/es not_active Expired - Lifetime
- 2004-12-20 PT PT04804949T patent/PT1697343E/pt unknown
- 2004-12-20 CA CA002548657A patent/CA2548657A1/en not_active Abandoned
- 2004-12-20 CN CN2004800416897A patent/CN1918146B/zh not_active Expired - Lifetime
- 2004-12-20 US US10/596,514 patent/US8044073B2/en active Active
- 2004-12-20 NZ NZ547796A patent/NZ547796A/en not_active IP Right Cessation
- 2004-12-20 EP EP04804949A patent/EP1697343B1/en not_active Expired - Lifetime
- 2004-12-20 TW TW093139737A patent/TWI356055B/zh not_active IP Right Cessation
- 2004-12-20 AR ARP040104806A patent/AR046971A1/es not_active Application Discontinuation
- 2004-12-20 RU RU2006125726/04A patent/RU2379302C2/ru not_active IP Right Cessation
- 2004-12-20 MY MYPI20045261A patent/MY141292A/en unknown
-
2006
- 2006-07-17 ZA ZA200605893A patent/ZA200605893B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004298457B2 (en) | 2010-05-27 |
| ES2328700T3 (es) | 2009-11-17 |
| BRPI0417811A (pt) | 2007-03-27 |
| TWI356055B (en) | 2012-01-11 |
| PT1697343E (pt) | 2009-09-16 |
| CA2548657A1 (en) | 2005-06-30 |
| TW200602327A (en) | 2006-01-16 |
| NZ547796A (en) | 2009-04-30 |
| RU2006125726A (ru) | 2008-01-27 |
| US20070099924A1 (en) | 2007-05-03 |
| JP2007514717A (ja) | 2007-06-07 |
| DK1697343T3 (da) | 2009-10-05 |
| RU2379302C2 (ru) | 2010-01-20 |
| MY141292A (en) | 2010-04-16 |
| ATE435222T1 (de) | 2009-07-15 |
| EP1697343A1 (en) | 2006-09-06 |
| EP1697343B1 (en) | 2009-07-01 |
| PL1697343T3 (pl) | 2009-12-31 |
| JP4915734B2 (ja) | 2012-04-11 |
| AU2004298457A1 (en) | 2005-06-30 |
| ZA200605893B (en) | 2007-11-28 |
| WO2005058869A1 (en) | 2005-06-30 |
| CN1918146B (zh) | 2011-09-14 |
| CN1918146A (zh) | 2007-02-21 |
| US8044073B2 (en) | 2011-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR046971A1 (es) | Aminobenzoimidazoles y benzoimidazoles como inhibidores de la replicacion del virus sincitial respiratorio | |
| CY1124737T1 (el) | Ανταγωνιστες lpa | |
| MX386187B (es) | Compuestos de benzo[b]tiofeno como agonistas de sting. | |
| CO2018008916A2 (es) | Compuestos de benzopirazol y análogos de estos | |
| EA202091506A1 (ru) | Триазол n-связанные карбамоил циклогексильные кислоты в качестве антагонистов lpa | |
| AR046959A1 (es) | Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio | |
| MX389672B (es) | Inhibidores de ssao de aminopirimidina | |
| EA201791304A1 (ru) | Производные изохинолина для лечения вич | |
| CO2017002998A2 (es) | Derivados de tetrahidronaftaleno que inhiben la proteína mcl-1 | |
| MX394576B (es) | Analogos detiadiazol y metodos para el tratamiento de afecciones relacionadas con la deficiencia del gen de supervivencia de las neuronas motoras (smn) | |
| MX381041B (es) | Compuesto cíclico tipo cumarina como inhibidor de mek y su uso. | |
| EA202091115A1 (ru) | Производные хиназолина, применяемые для лечения вич | |
| MX2019008435A (es) | Inhibidores selectivos de jak1. | |
| EA201692249A1 (ru) | Ингибиторы фосфатидилинозитол-3-киназы | |
| PE20200342A1 (es) | Derivados de indolina sustituidos como inhibidores de la replicacion virica de dengue | |
| CO2018008421A2 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| PE20200604A1 (es) | Derivados de indolina sustituidos como inhibidores de la replicacion virica de dengue | |
| SV2016005351A (es) | Derivados de indano e indolina y el uso de los mismos como activadores de la guanilato ciclasa soluble | |
| MX2017012295A (es) | Derivados formilados n-heterociclicos como inhibidores de fgfr4. | |
| JOP20190053A1 (ar) | مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط | |
| MX389999B (es) | Estabilizadores de mastocitos para el tratamiento de hipercitoquinemia e infeccion viral | |
| MX2016014939A (es) | Derivados de carboxamida. | |
| MX394245B (es) | Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia. | |
| JOP20190049A1 (ar) | مثبطات دوبامين-b-هيدروكسيلاز | |
| MX390044B (es) | Derivados de naftiridinona y su uso en el tratamiento de la arritmia. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |